Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice

Japanese Journal of Pharmacology

Volumn 78, Issue 2, 1998, Pages 191-197

  Sato, Kazuo ^a   Taniuchi, Yuta ^a   Kawasaki, Tomihisa ^a   Hirayama, Fukushi ^a   Koshio, Hiroyuki ^a   Matsumoto, Yuzo ^a   Iizumi, Yuichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Factor Xa inhibitor; Oral anticoagulant; Warfarin; YM 75466

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; CARBAMAZEPINE; CIMETIDINE; ERYTHROMYCIN; PHENYTOIN; PHYTOMENADIONE; RIFAMPICIN; THROMBOPLASTIN; UNCLASSIFIED DRUG; WARFARIN; [N [4 [(1 ACETIMIDOYL 4 PIPERIDYL)OXY]PHENYL] N [(7 AMIDINO 2 NAPHTHYL)METHYL]SULFAMOYL]ACETIC ACID MONOMETHANE SULFATE;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTHROMBIN TIME; THROMBOEMBOLISM;

EID: 0031793092     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.191     Document Type: Article

References (19)

1. Harder S and Thurmann P: Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 30, 416-444 (1996)
2. Hirsh J: Oral anticoagulant drugs. N Engl J Med 324, 1865-1875 (1991)
3. Wells PS, Holbrook AM, Crowther NR and Hirsh J: Interaction of warfarin with drugs and food. Ann Intern Med 121, 676-683 (1994)
4. Rosenberg JS, Beeler DL and Rosenberg RD: Activation of human prothrombin by highly purified human factors V and Xa in presence of human antithrombin. J Biol Chem 250, 1607-1617 (1975)
5. Taniuchi Y, Sakai Y, Hisamichi N, Kayama M, Mano Y, Sato K, Hirayama F, Koshio H, Matsumoto Y and Kawasaki T: Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human factor Xa. Thromb Haemost 79, 543-548 (1998)
6. Sato K, Kawasaki T, Taniuchi Y, Hirayama F, Koshio H and Matsumoto Y: YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time. Eur J Pharmacol 339, 141-146 (1997)
7. Sato K, Kawasaki T, Hisamichi N, Taniuchi Y, Hirayama F, Koshio H and Matsumoto Y: Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time. Br J Pharmacol 123, 92-96 (1998)
8. Broersma RJ, Kutcher LW, Heminger EF, Krstenansky JL and Marshall FN: Antithrombotic activity of a novel C-terminal hirudin analog in experimental animals. Thromb Haemost 65, 377-381 (1991)
9. Bernat A, Hoffmann P and Herbert JM: Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice. Thromb Haemost 76, 715-719 (1996)
10. Hérault JP, Bernat A, Pflieger AM, Lormeau JC and Herbert JM: Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase. J Pharmacol Exp Ther 283, 16-22 (1997)
11. Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JR, Atwood JL and Willoughby JM: Cimetidine: interaction with oral anticoagulants in man. Lancet 2, 317-319 (1979)
12. Toon S, Hopkins KJ, Garstang FM and Rowland M: Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. Eur J Clin Pharmacol 32, 165-172 (1987)
13. Hansen JM, Siersboek Nielsen K and Skovsted L: Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clin Pharmacol Ther 12, 539-543 (1971)
14. Heimark LD, Gibaldi M, Trager WF, Ra OR and Goulart DA: The mechanism of the warfarin-rifampin drug interaction in humans. Clin Pharmacol Ther 42, 388-394 (1987)
15. Bachmann K, Schwartz JI, Forney R Jr, Frogameni A and Jauregui LE: The effect of erythromycin on the disposition kinetics of warfarin. Pharmacology 28, 171-176 (1984)
16. Levine M and Sheppard I: Biphasic interaction of phenytoin with warfarin. Clin Pharm 3, 200-203 (1984)
17. Yasunaga K: Comparative studies on the effectiveness of vitamin K1 and vitamin K2. Naika Hokan 17, 279-283 (1970) (Abstr in English)
18. O'Reilly RA: Vitamin K and oral anticoagulant drugs as competitive antagonists in man. Pharmacology 7, 149-158 (1972)
19. Qureshi GD, Reinders TP, Swint JJ and Slate MB: Acquired warfarin resistance and weight-reducing diet. Arch Intern Med 141, 507-509 (1981)